Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD56+CD3- NK Cells”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)WithdrawnNCT01336478
What this trial is testing

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells
Imperial College London
Testing effectiveness (Phase 2)WithdrawnNCT01639456
What this trial is testing

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota
Not applicableStudy completedNCT02301065
What this trial is testing

Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors

Who this might be right for
Hematologic Malignancies
St. Jude Children's Research Hospital 35
Not applicableEnded earlyNCT03152526
What this trial is testing

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Who this might be right for
Acute Myelogenous Leukemia
Miltenyi Biotec B.V. & Co. KG 1
Testing effectiveness (Phase 2)UnknownNCT01220544
What this trial is testing

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Who this might be right for
Acute Myeloid LeukemiasAdvanced Hematological MalignanciesIndication for Allogeneic Stem Cell Transplantation+1 more
Charite University, Berlin, Germany 30